111, Inc. (YI) News
Follow 111, Inc. (YI) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 13 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
111 Special Committee Comprises Three Independent Directors >YI
111 Special Committee Comprises Three Independent Directors >YI
NEWS | Sep 28, 2026, 08:41 AM UTC
L
111 Is a Tech-Enabled Healthcare Platform Co in China >YI
111 Is a Tech-Enabled Healthcare Platform Co in China >YI
GEOPOLITICS | Sep 28, 2026, 08:38 AM UTC
L
111 Hasn't Made Any Decisions Regarding Proposal or Any Alternative Strategic Options >YI
111 Hasn't Made Any Decisions Regarding Proposal or Any Alternative Strategic Options >YI
NEWS | Sep 28, 2026, 08:35 AM UTC
L
111 Special Committee to Also Evaluate Other Potential Strategic Alternatives >YI
111 Special Committee to Also Evaluate Other Potential Strategic Alternatives >YI
NEWS | Sep 28, 2026, 08:32 AM UTC
L
111 Special Committee to Consider, Evaluate Previously Announced Preliminary, Nonbinding Proposal Letter Dated Sept. 16 >YI
111 Special Committee to Consider, Evaluate Previously Announced Preliminary, Nonbinding Proposal Letter Dated Sept. 16 >YI
NEWS | Sep 28, 2026, 08:32 AM UTC
L
111 Establishes Special Committee >YI
111 Establishes Special Committee >YI
NEWS | Sep 28, 2026, 08:31 AM UTC
L
111, Inc. Announces Establishment of the Special Committee
SHANGHAI, Sept. 28, 2026 // -- 111, Inc. ( "111" or the "Company") (NASDAQ:YI), a leading tech-enabled healthcare platform company in China, announced today that the special committee (the "Special Committee"), comprisin
GEOPOLITICS | Sep 28, 2026, 08:30 AM UTC
M
Junling Liu files 13D for 111, Inc. take-private bid
Junling Liu, co-founder and CEO of 111, Inc., disclosed a 42.1% stake on Schedule 13D and, with partners, filed to acquire remaining shares. The consortium controls about 91.4% of voting power and offered $0.226 per Clas
MNA | Sep 17, 2026, 10:28 AM UTC
M
111, Inc. gets $4.52/ADS preliminary go-private proposal
111, Inc. says co-founders and a sponsor made an unsolicited preliminary non-binding proposal to buy remaining shares for $0.226 per Class A share, or $4.52 per ADS, funded with equity. The board has not evaluated the pr
MNA | Sep 17, 2026, 08:26 AM UTC
M
111 Inc receives unsolicited preliminary non-binding acquisition proposal
111 Inc received an unsolicited preliminary non-binding proposal to acquire the company (YI).
EQUITY | Sep 17, 2026, 08:25 AM UTC
M
111 Inc Q2 revenue falls 28% after asset-light shift
Chinese healthcare platform 111 Inc reported Q2 revenue down 28% amid an asset-light shift.
EQUITY | Sep 17, 2026, 07:12 AM UTC
M
111, Inc. reports Q2 revenue drop and wider net loss
111, Inc. reported unaudited Q2 2026 net revenues of RMB2.3B, down 28.3% YoY, and a net loss of RMB31.7M versus a net loss of RMB7.3M a year ago. Cash, restricted cash and short-term investments were RMB381.1M as of June
EQUITY | Sep 17, 2026, 07:01 AM UTC
L
YI - 111, Inc. Announces Second Quarter 2026 Unaudited Financial Results
YI - 111, Inc. Announces Second Quarter 2026 Unaudited Financial Results
EARNINGS | Sep 17, 2026, 07:00 AM UTC